During the past decade, Himeji Central Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Himeji Central Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Himeji Central Hospital" are "Alzheimer Disease" (2 trials), "Colorectal Cancer" (2 trials), "Central Nervous System Diseases" (1 trials) and "Diagnostic Imaging" (1 trials). Many other conditions were trialed in "Himeji Central Hospital" in a lesser frequency.

Most popular intervention types in "Himeji Central Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "Donanemab" (1 trials), "Gadobutrol (Gadavist, Gadovist, BAY86-4875)" (1 trials) and "Gadoteridol (ProHance)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Himeji Central Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Himeji Central Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Himeji Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Himeji Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".